Chronic Phase Chronic Myeloid Leukemia

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Phase Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib)

Completed
  • Chronic Phase Chronic Myeloid Leukemia
  • Duarte, California
  • +27 more
Dec 7, 2021

Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

Terminated
  • Chronic Phase Chronic Myeloid Leukemia
  • Ponatinib 30 mg QD
  • +2 more
  • Bruxelles, Belgium
    Cliniques Universitaire Saint-Luc (Site 058)
Oct 28, 2021

Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL

Active, not recruiting
  • Chronic Phase Chronic Myeloid Leukemia
    • Chicago, Illinois
    • +24 more
    May 24, 2021

    Chronic Phase Chronic Myeloid Leukemia Trial in Tampa (Nilotinib, Ruxolitinib)

    Completed
    • Chronic Phase Chronic Myeloid Leukemia
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 4, 2021

    Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia Trial

    Completed
    • Chronic Phase Chronic Myeloid Leukemia
    • +4 more
    • Toronto, Ontario, Canada
      Princess Margaret Hospital / University Health Network
    Oct 29, 2020

    Chronic Phase Chronic Myeloid Leukemia Trial in Austria (P1101)

    Completed
    • Chronic Phase Chronic Myeloid Leukemia
    • Wels, Oberösterreich, Austria
    • +3 more
    Jan 3, 2019

    Chronic Phase Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib)

    Completed
    • Chronic Phase Chronic Myeloid Leukemia
    • Anaheim, California
    • +21 more
    Nov 17, 2016